Literature DB >> 15659547

Receptor editing in peripheral B cell tolerance.

Jeffrey S Rice1, Jeffrey Newman, Chuansheng Wang, Daniel J Michael, Betty Diamond.   

Abstract

Receptor editing or secondary Ig gene rearrangement occurs in immature, autoreactive B cells to maintain self-tolerance. Here we show that nonspontaneously autoimmune mice immunized with a peptide mimetope of DNA develop peptide- and DNA-reactive antibodies. Antigen-specific B cells display a follicular B cell phenotype. As these cells move into the memory compartment, many express RAG protein and acquire expression of both kappa and lambda light chains. Thus, this study provides evidence for receptor editing occurring in a mature, antigen-activated B cell population. Because the receptor editing observed here occurred in an autoreactive response to antigen, it may function to maintain peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659547      PMCID: PMC547880          DOI: 10.1073/pnas.0409217102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development.

Authors:  S Hande; E Notidis; T Manser
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

2.  Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease.

Authors:  S K Ray; C Putterman; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.

Authors:  T Onizuka; M Moriyama; T Yamochi; T Kuroda; A Kazama; N Kanazawa; K Sato; T Kato; H Ota; S Mori
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

4.  Characterization of B cells expressing recombination activating genes in germinal centers of immunized mouse lymph nodes.

Authors:  M Hikida; M Mori; T Kawabata; T Takai; H Ohmori
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Peptide inhibition of glomerular deposition of an anti-DNA antibody.

Authors:  B Gaynor; C Putterman; P Valadon; L Spatz; M D Scharff; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells.

Authors:  M Hikida; M Mori; T Takai; K Tomochika; K Hamatani; H Ohmori
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

7.  Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.

Authors:  S Han; B Zheng; D G Schatz; E Spanopoulou; G Kelsoe
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  BCL-6 protein is expressed in germinal-center B cells.

Authors:  G Cattoretti; C C Chang; K Cechova; J Zhang; B H Ye; B Falini; D C Louie; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

9.  Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle.

Authors:  L Mandik-Nayak; A Bui; H Noorchashm; A Eaton; J Erikson
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition.

Authors:  C Putterman; B Diamond
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  27 in total

1.  Differential expression of FCRLA in naïve and activated mouse B cells.

Authors:  Evdokiya S Reshetnikova; Ludmila V Mechetina; Olga Y Volkova; Sergey V Guselnikov; Nikolai A Chikaev; Dorottya Kövesdi; Boris Alabyev; Gabriella Sármay; Peter D Burrows; Alexander M Najakshin; Alexander V Taranin
Journal:  Cell Immunol       Date:  2011-10-22       Impact factor: 4.868

Review 2.  Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.

Authors:  Jolien Suurmond; Betty Diamond
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

3.  Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity.

Authors:  C Sirac; C Carrion; S Duchez; I Comte; M Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  SLAP deficiency decreases dsDNA autoantibody production.

Authors:  Lisa K Peterson; Luke F Pennington; Laura A Shaw; Meredith Brown; Eric C Treacy; Samantha F Friend; Øyvind Hatlevik; Kira Rubtsova; Anatoly V Rubtsov; Leonard L Dragone
Journal:  Clin Immunol       Date:  2013-12-31       Impact factor: 3.969

5.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

6.  IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells.

Authors:  Yi Yan; Ying-Hua Wang; Betty Diamond
Journal:  J Autoimmun       Date:  2011-12-07       Impact factor: 7.094

Review 7.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

8.  Patterns of receptor revision in the immunoglobulin heavy chains of a teleost fish.

Authors:  Miles D Lange; Geoffrey C Waldbieser; Craig J Lobb
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 9.  DNA-reactive B cells in lupus.

Authors:  Jolien Suurmond; Justine Calise; Susan Malkiel; Betty Diamond
Journal:  Curr Opin Immunol       Date:  2016-08-06       Impact factor: 7.486

10.  Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region.

Authors:  Laurent Verkoczy; M Anthony Moody; T Matt Holl; Hilary Bouton-Verville; Richard M Scearce; Jennifer Hutchinson; S Munir Alam; Garnett Kelsoe; Barton F Haynes
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.